Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III lot-consistency and formulation-comparison study of Rotarix liquid oral rotavirus vaccine in healthy infants
2006-003239-61Phase 3Completed
- Sponsor
- GSK
- Start
- Jul 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised trial of human rotavirus RIX4414 strain vaccine in rotaviral diarrhea (4 arms), sponsored by GSK. Primary endpoints: Serum anti-rotavirus IgA antibody concentration at Visit 3, Lot-to-lot consistency of liquid formulation and 1 more. Started Jul 2006; status: completed.
02
Drugs
human rotavirus RIX4414 strain vaccine
03
Conditions
rotaviral diarrhea
Beyond the preview
Go deeper on 2006-003239-61.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003239-61.